Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Monte Rosa Therapeutics, Inc.GLUE · Entity 4828 | Director | March 24, 2025 | March 25, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Monte Rosa Therapeutics, Inc.
Report date March 24, 2025 · Filed March 25, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 10,000 |
Reported balance
After 2025-03-24 transaction · row 1
1 source rowRow 1 · 2025-03-24 · Purchase · Acquired 10,000 · Balance 10,000 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 24, 2025 Filed Mar 25, 2025 18:32 UTC | Monte Rosa Therapeutics, Inc. GLUE · Entity 4828 | PurchaseCommon Stock | 10,000 | $5.84 | $58,383.00 |
DisclosureSEC source: 0000950170-25-044633 · ownership.xml · nonDerivative · entry 1 Leo Chandra P. · CIK 0001855642 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,000 Read SEC document |
| June 23, 2021 Filed Jun 25, 2021 17:01 UTC | Monte Rosa Therapeutics, Inc. GLUE · Entity 4828 | GrantStock Option (Right to Buy) · Derivative | 47,132 | $0.00 Strike: $19.00 | $0.00 |
DisclosureSEC source: 0000899243-21-025982 · doc4.xml · derivative · entry 1 Leo Chandra P. · CIK 0001855642 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,132 Underlying: Common Stock · 47,132 shares Expires 2031-06-22 F1 · derivative.exercise_date: This option shall vest in 36 substantially equal monthly installments, with the first installment vesting on June 28, 2021. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.